17
Mar
2025
Why Cell & Gene Therapy Companies Should Talk with RFK Jr.
As the CEO of the cell and gene therapy advocacy organization the Alliance for Regenerative Medicine (ARM), I’ve been asked one question more than any other amid the constant barrage of news headlines the past two months. How are you approaching the Trump Administration? I hear it from across our community, including biotechnology companies, academic and medical research institutions, patient... Read More